Application Value of MDCT on Diagnosing Nephroblastoma
Author：DING Wei
affiliation：CT Room, People's Hospital of Minquan County, Shangqu 476800, Henan Province, China
PDFAbstract
Objective To investigate the application value of MDCT on diagnosing nephroblastoma. Methods 46 cases with nephroblastoma in our hospital from March 2015 to May 2016 were selected and retrospectively analyzed. All patients were given surgery or aspiration biopsy. They were all given ultrasonic testing and MDCT before surgery, ultrasonic testing results were seen as control group, MDCT results were seen as observation group, compare the sensibility and specificity of the two methods. Results Positive rate between ultrasonic testing (52.17%) and MDCT (63.04%) had no obvious difference, the difference was not statistic significant (P>0.05), sensibility and specificity between ultrasonic testing [(96.55%),(94.12%)] and MDCT [(41.18%),(58.33%)] had obvious difference, the difference was statistic significant (P<0.05). Conclusion In the treatment of MDS, arsenic trioxide and HAG regimen has similar effect, but arsenic trioxide has less adverse reactions and is worthy of clinic use.
【Keyword】MDCT; Nephroblastoma
【Chart number】R322.6+1
【Document Identification Number】A
【DOI】10.3969/j.issn.1009-3257.2017.03.015
Journal of Rare Diseases
th24Volume， th 3 Issue
2019Year11Month
Related articles
Editor email：（1）中国CT和MRI杂志：ctmri@vip.163.com；（2）罕少疾病杂志：hs1999@vip.163.com
Contact number：0755-83695203
Our address：
English
简体中文
logged in
Wechat
TouTiao